#JSWInfra to acquire under development slurry pipeline project from JSW Utkal Steel for ₹1,700 crore #FinancialNews #StockMarket #Investment #Trading #JSWInfra to acquire under development slurry pipeline project from JSW Utkal Steel for ₹1,700 crore #FinancialNews #StockMarket #Investment #Trading

Posted on by Raj Gaurav Rai

#JSWInfra to acquire under development slurry pipeline project from JSW Utkal Steel for ₹1,700 crore #FinancialNews #StockMarket #Investment #Trading #JSWInfra to acquire under development slurry pipeline project from JSW Utkal Steel for ₹1,700 crore #FinancialNews #StockMarket #Investment #Trading

Please follow and like us:

Related Posts

Market@noon Nifty down by 59 points (-0.25%) Top Gainers : TATAMTRDVR +5.10%, TATAMOTORS +5.03% Top Losers : AXISBANK -6.45%, IRFC -3.57% #StockMarket #FinancialNews #Trading Market@noon Nifty down by 59 points (-0.25%) Top Gainers : TATAMTRDVR +5.10%, TATAMOTORS +5.03% Top Losers : AXISBANK -6.45%, IRFC -3.57% #StockMarket #FinancialNews #Trading

Market@noonNifty down by 59 points (-0.25%) Top Gainers : TATAMTRDVR +5.10%, TATAMOTORS +5.03% Top Losers : AXISBANK -6.45%, IRFC -3.57% #StockMarket #FinancialNews #Trading Market@noon Nifty […]

India Real Estate — ₹1.95 Lakh Crore Sales FY26, 17% Growth | Godrej #1 | Oberoi Enters Gurugram | Best Stocks to Buy 2026

India’s top 28 listed real estate firms hit Rs 1.95 lakh crore in sales bookings in FY26 — up 17% YoY. Godrej Properties leads, followed by Prestige and Lodha. Oberoi Realty enters Gurugram with 360 North project (GDV Rs 2,500-3,000 crore). Reasons for strong demand: rate cuts, rising incomes, urbanisation, NRI buying. Best stocks: DLF, Prestige, Godrej, Oberoi, Sobha. Full sector analysis.

NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends   https://earnfree.in/latest NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends   https://ift.tt/jmZBx8V

NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). […]

Exit mobile version